发明名称 |
CELL POPULATION WHICH CO-EXPRESSES CD49c AND CD90 |
摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a new, improved and effective method for treating diseases and conditions, particularly neurological and cardiac diseases and conditions in humans. <P>SOLUTION: There is provided an isolated cell population wherein cells of the isolated cell population are derived from bone marrow; >91% of the cells of the cell population co-express cell surface polypeptides CD49c and CD90; the cells of the isolated cell population express at least one trophic factor; the cells of the isolated cell population do not express polypeptide CD34, CD45 or bonesialoprotein (BSP); and the cell population maintains a doubling time of≤30 h after 30 cell doublings. Furthermore, a pharmaceutical composition includes the cell population. <P>COPYRIGHT: (C)2010,JPO&INPIT</p> |
申请公布号 |
JP2010172334(A) |
申请公布日期 |
2010.08.12 |
申请号 |
JP20100040861 |
申请日期 |
2010.02.25 |
申请人 |
GARNET BIOTHERAPEUTICS INC |
发明人 |
HO TONY W;KOPEN GENE C;RIGHTER WILLIAM F;RUTKOWSKI J LYNN;HERRING W JOSEPH;RAGAGLIA VANESSA;WAGNER JOSEPH |
分类号 |
C12N5/077;C12N15/09;A61K35/12;A61K35/28;A61K35/34;A61K35/36;A61K35/44;A61K35/50;A61P9/00;A61P9/04;A61P9/10;A61P19/08;A61P21/00;A61P21/04;A61P25/00;A61P25/16;A61P35/00;C12N5/0775;C12N5/0797;C12Q1/68 |
主分类号 |
C12N5/077 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|